Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. (Q34369863)

1 August 2017

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT. (English)

1 reference

1 August 2017

0 references

1

Henry Krum

1 reference

1 August 2017

8

Jay N Cohn

1 reference

1 August 2017

Peter Carson

2

1 reference

1 August 2017

Csaba Farsang

3

1 reference

1 August 2017

Aldo P Maggioni

4

1 reference

1 August 2017

Robert D Glazer

5

1 reference

1 August 2017

Nora Aknay

6

1 reference

1 August 2017

Yann-Tong Chiang

7

1 reference

1 August 2017

1 December 2004

1 reference

European Journal of Heart Failure

1 August 2017

1 reference

1 August 2017

6

1 reference

1 August 2017

7

1 reference

1 August 2017

937-945

1 reference

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Therapeutic role of angiotensin II receptor blockers in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Candesartan and heart failure: the allure of CHARM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.09.005

10.1016/J.EJHEART.2004.09.005

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference